Rocket Lab (NASDAQ: RKLB) has had a wild year. The share hit $37.57 in November 2025, then climbed to $151.00 on 27 May 2026. By the close of 12 October 2026 it was back at $65.71, more than half-way down from that peak. In between, the company reported record sales, agreed to buy Iridium for about $8 billion, and saw its big new rocket, Neutron, slip towards the end of the year. This page explains what happened in easy words, what the numbers show, and what a careful investor should check.
Quick answer
There is no fact-based “target” for 2030. Analysts quote an average 12-month target near $104.71, but analysts change targets often, and they have also been cutting some of them. Below we show clean numbers, simple maths and a plain opinion, so that you can decide for yourself.
Rocket Lab share price today
Rocket Lab trades on the NASDAQ in the United States. The figures below are from the close of 12 October 2026. Prices change every second while the market is open, so please check a live quote before you trade.
| Item | Figure | Note |
|---|---|---|
| Ticker | RKLB (NASDAQ) | Company name is now Rocket Lab Corp |
| Last close | $65.71 | 12 Oct 2026, down 4%; previous close $68.21 |
| Last 5 sessions | About −13% | Sharp week of selling |
| 52-week high | $151.00 | 27 May 2026 |
| 52-week low | $37.57 | 21 Nov 2025 |
| 50-day average | $70.52 | Price is below it |
| 200-day average | $84.44 | Price is well below it |
| Market value | About $39.3 billion | Data sites show $39–41 billion |
| Beta | About 2.9 | Moves much more than the market |
The close is about 56% below the May high and about 75% above the November low. Both facts are true at the same time, which shows how fast this stock moves.
Why the price rose and then fell: a dated timeline
| When | What happened | Why it matters |
|---|---|---|
| 21 Nov 2025 | Share touched $37.57 | The low of the last 52 weeks |
| 27 May 2026 | Share touched $151.00 | The peak; space and AI stocks were in favour |
| 28–29 Jun 2026 | Deal to buy Iridium at $54 a share (about $8.0 billion value) | A big step beyond rockets, but also a big bill |
| 6 Jul 2026 | Founder Peter Beck sold about 3.28 million shares at $87.43 | Insider selling, reported in a filing |
| 10 Aug 2026 | Q2 results: record sales, wider loss than expected | Shares fell after the report |
| 15 Sep 2026 | Company said the Iridium deal is fully financed | It raised about $1.94 billion by selling new shares |
| 1 Oct 2026 | CFO sold 140,157 shares under a pre-set plan; Citi started coverage with a Buy | Mixed signals in one day |
| 12 Oct 2026 | Close at $65.71, down 4% | Part of a 13% fall in five sessions |
What does Rocket Lab do?
Rocket Lab was founded by Peter Beck in New Zealand in 2006 and is now run from Long Beach, California. Most people know it for the small Electron rocket, which carries satellites into orbit. It also flies HASTE, a version used for high-speed test flights for the US government.
The larger part of the business, however, is building satellites and parts: solar panels, radios, star trackers, reaction wheels and complete satellite “buses”. Think of it as a company that makes the car and also runs the taxi service. Its launch pads are at Mahia in New Zealand and at Wallops Island in Virginia, where the new Neutron rocket is being prepared.
Where the money comes from
| Segment (Q2 2026) | Revenue | Share of total | What it includes |
|---|---|---|---|
| Space Systems | $189.5 million | About 81% | Satellites, solar, components, and the new Mynaric business |
| Launch Services | $44.6 million | About 19% | Electron and HASTE flights; six launches in the quarter |
| Total | About $234 million | 100% | Record quarter |
Latest results: April to June 2026
| Measure | Q2 2026 | Q2 2025 | Reading |
|---|---|---|---|
| Revenue | $234 million | About $144 million | Up 62%, a record |
| Net loss | $49.3 million | $66.4 million | Smaller loss, but worse than analysts expected |
| Loss per share | $0.08 | $0.13 | Analysts had expected about $0.06 to $0.07 |
| Adjusted EBITDA | Loss of $8.8 million | Loss of $27.6 million | Moving towards break-even |
| Order backlog | $2.36 billion | — | Up 137%, a record |
| Q3 2026 revenue guide | $250–265 million | — | Another record expected |
In plain words: sales are growing very fast, and the loss is shrinking compared with last year. Yet the company still spends more cash than it earns. The company also guided that its adjusted EBITDA loss will widen a little in Q3, to about $17–23 million.
Cash, losses and burn
| Item | Figure | Meaning |
|---|---|---|
| Cash and securities (30 Jun 2026) | About $2.39 billion | Up from about $1.10 billion in Dec 2025 |
| Operating cash flow, Q2 | −$84.1 million | Worse than −$50.3 million in Q1 |
| Free cash flow, Q2 | About −$110 million | Cash spent on running the business and building |
| Debt | Not confirmed | Sources disagree; check the company’s 10-Q |
The cash pile is strong and buys time. But at a burn of roughly $100 million a quarter, plus the money needed for Iridium, the company will keep selling shares or raising debt unless profits arrive. Selling shares gives existing owners a smaller slice of the company.
The Iridium deal, explained simply
Iridium runs a network of satellites that gives phone and data coverage anywhere on Earth. Rocket Lab agreed to buy it so that it can earn steady subscription-type income instead of depending only on one-time launches and satellite builds.
| Term | Detail |
|---|---|
| Price | $54 per Iridium share, in cash and Rocket Lab stock |
| Total value | About $8.0 billion including debt |
| Financing | A $3.6 billion bridge loan was lined up first, then replaced after about $1.94 billion was raised by selling 29.3 million new shares (about $66 each) |
| Timing | Closing is expected in mid-2027 |
| Conditions | Iridium shareholders and regulators must approve |
Neutron: the big test
Neutron is Rocket Lab’s medium-size reusable rocket, meant to compete with SpaceX for bigger satellite and government launches. Reports after the Q2 results say the hardware is “converging on the pad” for the fourth quarter of 2026, but Peter Beck said the window for a launch this year is “narrowing”. One prediction market put the chance of a 2026 first launch at only about 14%. That last number is a guess by traders, not company guidance.
Why does it matter? Management has said that adjusted EBITDA is expected to turn positive only in the quarter after Neutron’s first successful flight. So the rocket is tied to the profit story. A clean first flight could lift the share. A failure or a long delay could hurt it badly.
Is the price ahead of the business?
A simple check is price-to-sales (P/S). Take the latest quarter’s sales of $234 million and multiply by four: about $0.94 billion a year. The market value of about $39 billion is then around 42 times that figure (our own rough sum). Most investors would call that expensive. It only works if sales grow several times over.
The table shows what share price different 2030 sales and P/S levels would give. It assumes about 608 million shares (the July count of 579 million plus the 29 million sold for Iridium) and ignores new shares from the deal, so real values could be lower.
| 2030 yearly sales (example) | If P/S is 8 | If P/S is 12 | If P/S is 16 |
|---|---|---|---|
| $2 billion | about $26 | about $39 | about $53 |
| $3 billion | about $39 | about $59 | about $79 |
| $4 billion | about $53 | about $79 | about $105 |
Read this carefully: for the share to be well above today’s $65.71 in 2030, the company needs sales of roughly $3–4 billion and investors who are still willing to pay a rich multiple. These are examples of maths, not forecasts.
Who owns Rocket Lab, and who is selling?
- Shares: about 579 million in July 2026, plus about 29 million new ones sold for the Iridium deal.
- Founder Peter Beck: a filing in March 2026 showed about 46.4 million shares (about 7.5%), mostly through a trust. In July he sold about 3.28 million shares at $87.43.
- CFO Adam Spice: sold 140,157 shares for about $9.9 million on 1 October under a plan set up in June. He still holds more than 1.15 million shares.
- Institutions: big funds such as Vanguard hold large stakes. Data sites give very different percentages (from about 39% to about 72%), so we do not quote one figure.
Insider selling under pre-set plans is common and is not proof of trouble. Still, it is worth watching when many sales happen together.
What do analysts say?
| Source | View | Target |
|---|---|---|
| Consensus (about 25 analysts) | 4 Strong Buy, 15 Buy, 5 Hold, 1 Sell | About $104.71 average |
| Citigroup | Buy (started 1 Oct 2026) | $105 |
| TD Cowen | Buy | Cut from $120 to $90 |
| Cantor Fitzgerald | Overweight | $122 |
| Barclays | Overweight (started coverage) | Not stated |
The average target is about 59% above the current price. That sounds exciting, but targets are opinions, they were often set when the price was higher, and several firms are lowering them. Treat them as one input, not as a promise.
Share price target 2026 to 2030: simple maths, not a forecast
The formula is easy: future price = today’s price × (1 + yearly change) ^ number of years. We start from $65.71 and show three cases. A fall case is included on purpose, because this share has already fallen by more than half once in 2026.
| Year | Cautious (−10% a year) | Steady (+12% a year) | Strong (+25% a year) |
|---|---|---|---|
| 2026 (start) | $65.71 | $65.71 | $65.71 |
| 2027 | $59.14 | $73.60 | $82.14 |
| 2028 | $53.23 | $82.43 | $102.67 |
| 2029 | $47.90 | $92.32 | $128.34 |
| 2030 | $43.11 | $103.40 | $160.42 |
What $1,000 could become (example)
$1,000 buys about 15 shares at $65.71. After four years, in the three examples, it would be worth about $656 (cautious), $1,574 (steady) or $2,441 (strong). This ignores brokerage, taxes and currency changes. Indian investors should convert at the day’s USD/INR rate and ask a tax adviser about the rules for foreign shares.
What could help Rocket Lab
- Fast growth: sales up 62% and a $2.36 billion backlog give a long runway.
- Cash: about $2.4 billion on hand, so the company is not short of money today.
- A first clean Neutron flight: would prove the rocket and open bigger contracts.
- Recurring income from Iridium: if the deal closes and works, revenue becomes steadier.
- Government demand: defence and space agencies keep placing orders; new contracts above $1 billion were reported in Q3.
What could hurt Rocket Lab
- High price: about 42 times yearly sales. Small disappointments can cause big falls.
- Neutron delay or failure: profit is tied to this rocket.
- Cash burn: about $100 million a quarter, before Iridium costs.
- More shares: new shares sold for Iridium and future raises can dilute owners.
- Competition: SpaceX is far bigger and can cut prices.
- Deal risk: Iridium needs approvals and must be integrated well.
- Big swings: a beta near 3 means the share can move several times more than the market.
Dividend and buyback: Rocket Lab pays no dividend and has no buyback. It spends its money on growth, so it is not a share for regular income.
Our opinion and suggestions (not a buy or sell call)
The business has improved a lot. The share is already 56% below its peak, which some investors see as an opening and others see as a warning. Both readings are fair. Your decision should depend on your goal, your time frame and how much loss you can take.
| Type of investor | A simple way to think |
|---|---|
| New or small investor | Do not rush. If you want exposure, think of 2 to 4 small purchases over several weeks, not one big one. Keep it a small slice of your money. Never borrow to buy it. |
| Already holding at a profit or loss | Decide your rule in advance: how much you will hold and what would make you sell. Avoid changing the plan in a panic on a red day. |
| Long-term investor (5+ years) | Judge the next 3–4 quarters: Neutron flight, margin, cash burn and how the Iridium deal is financed. If these improve, the story gets stronger. |
| Short-term trader | Daily moves of 4–5% are normal here. Use a small size and a clear exit. This is not for money you will need soon. |
| Income seeker | This is not for you. There is no dividend. |
Other suggestions: (1) Keep a solid core in broad, low-cost funds and use stocks like this only as a small extra. (2) Do not put more than a small part of your money in one fast-moving share. (3) Read the company’s own results and 10-Q, not only headlines. (4) Remember the currency: a falling rupee helps and a rising rupee hurts a dollar share. (5) If you are unsure, speak to a SEBI-registered adviser who knows your full situation.
What to track every quarter
- Revenue growth and whether it reaches the $250–265 million guide for Q3.
- Neutron news: test milestones, the first-flight date and the result.
- Operating cash flow and free cash flow, not only the accounting loss.
- Gross margin and adjusted EBITDA: do they move towards profit?
- Backlog and new contracts, especially large government awards.
- Share count and any new share sales or debt for Iridium.
- Insider sales and any approval news on the Iridium deal.
Key terms in simple words
| Term | Meaning |
|---|---|
| Backlog | Value of signed work that is still to be delivered. |
| Adjusted EBITDA | Operating profit or loss before interest, tax and some non-cash costs. |
| Free cash flow | Cash from operations minus money spent on equipment and buildings. |
| P/S ratio | Market value divided by yearly sales. Shows how many years of sales you pay for. |
| Dilution | When new shares are issued, each old share owns a smaller part of the company. |
| Beta | How much a share moves compared with the market. Above 1 means bigger swings. |
| Bridge loan | A short-term loan used until longer-term money is raised. |
| 10b5-1 plan | A pre-set plan that lets insiders sell shares on fixed terms. |
| LRS | RBI’s Liberalised Remittance Scheme, which lets Indians send money abroad to invest (limit US$250,000 a financial year). |
Frequently asked questions
Why did Rocket Lab stock fall from $151 to about $66?
There is no single cause. Likely factors include a loss wider than expected in Q2, worries about the Neutron timeline, the large Iridium deal and new shares, insider sales and a broad cooling in high-growth space stocks. These are reasons reported by market coverage, not certainties.
What is the Rocket Lab share price today?
The close on 12 October 2026 was $65.71. Check a live quote on NASDAQ or your broker’s app before you trade.
What is the Rocket Lab stock price target for 2030?
No one knows. Our examples give about $43 (cautious), $103 (steady) and $160 (strong), starting from $65.71. Real prices will depend on sales, profit, share count and how much investors will pay.
What do Wall Street analysts expect for Rocket Lab?
The average 12-month target is about $104.71, with most analysts rating the stock Buy or Strong Buy. Some have cut targets recently, for example TD Cowen from $120 to $90.
Is Rocket Lab a good stock to buy now?
It has strong growth and a big cash pile, but also losses, a high valuation and a key rocket test ahead. It suits investors who can accept big swings. See our opinion section and decide for your own goals.
What is the Iridium deal?
Rocket Lab agreed to buy Iridium Communications at $54 a share, about $8.0 billion including debt, in cash and stock. It is expected to close in mid-2027, subject to shareholder and regulatory approval.
When will Neutron launch?
The company has pointed to the fourth quarter of 2026, but the CEO has said the window is narrowing, so a first flight in 2027 is possible. Check the company’s investor page for updates.
Does Rocket Lab pay a dividend?
No. It reinvests in growth and has no dividend or buyback.
Can Indians buy Rocket Lab shares?
Yes, through brokers that offer US stocks, under the RBI’s Liberalised Remittance Scheme (limit US$250,000 a financial year). Check fees, tax rules and the exchange rate with your broker or a tax adviser first.
When are the next results?
Rocket Lab usually reports Q3 results in early November. Check the investor relations page for the exact date.
How we prepared this article
We used the company’s Q2 2026 results release and 10-Q, SEC filings, quote pages and market news, and wrote the date next to each price. Where sources disagreed (for example on debt and on institutional ownership), we say so or leave the figure out. Scenario numbers are our own simple maths. We update this page after each quarterly result. If you spot a wrong figure, please tell us.
Conclusion
Rocket Lab has moved from a small launch company to a fast-growing space business with record sales, a record backlog and a large cash pile. It is also loss-making, about to take on a very large acquisition, and waiting for the first flight of a rocket that matters to its profit. The share has already shown how sharply it can swing. The wise path is to follow the next few quarters, size your position carefully and never invest money you cannot afford to lose.
Related reading
- ChatGPT (OpenAI) share price in India: can you buy it?
- Wipro share price target: what happened and what next
Watch: a related video
Video by CNBC Television: Watch CNBC’s full interview with Rocket Lab CEO Peter Beck. This interview was recorded earlier, before the Iridium deal, so please check the upload date. It is shown for learning only and is not investment advice.
Sources
- SEC filing (8-K): Rocket Lab Q2 2026 results, 10 August 2026
- SEC filing (10-Q): quarter ended 30 June 2026
- Nasdaq: Rocket Lab Q2 2026 financial results press release
- CoinCentral: share move, CFO sale and analyst ratings (13 Oct 2026)
- TrendSpider: Q2 earnings and Neutron timeline
- CNBC: RKLB quote
- SEC filing (Schedule 13D/A): Peter Beck holdings
- Rocket Lab investor relations
Price data as of the 12 October 2026 close. Results data for the quarter ended 30 June 2026. Last reviewed 13 October 2026.
